{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T13:08:42Z","timestamp":1792156122202,"version":"4.4.0"},"reference-count":75,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T00:00:00Z","timestamp":1684108800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["3\/1\/1(20)\/2022-NCD-I"],"award-info":[{"award-number":["3\/1\/1(20)\/2022-NCD-I"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Arterial wall damage in Takayasu arteritis (TAK) can progress despite immunosuppressive therapy. Vascular fibrosis is more prominent in TAK than in giant cell arteritis (GCA). The inflamed arterial wall in TAK is infiltrated by M1 macrophages [which secrete interleukin-6 (IL-6)], which transition to M2 macrophages once the inflammation settles. M2 macrophages secrete transforming growth factor beta (TGF-\u03b2) and glycoprotein non-metastatic melanoma protein B (GPNMB), both of which can activate fibroblasts in the arterial wall adventitia. Mast cells in the arterial wall of TAK also activate resting adventitial fibroblasts. Th17 lymphocytes play a role in both TAK and GCA. Sub-populations of Th17 lymphocytes, Th17.1 lymphocytes [which secrete interferon gamma (IFN-\u03b3) in addition to interleukin-17 (IL-17)] and programmed cell death 1 (PD1)-expressing Th17 (which secrete TGF-\u03b2), have been described in TAK but not in GCA. IL-6 and IL-17 also drive fibroblast activation in the arterial wall. The Th17 and Th1 lymphocytes in TAK demonstrate an activation of mammalian target organ of rapamycin 1 (mTORC1) driven by Notch-1 upregulation. A recent study reported that the enhanced liver fibrosis score (derived from serum hyaluronic acid, tissue inhibitor of metalloproteinase 1, and pro-collagen III amino-terminal pro-peptide) had a moderate-to-strong correlation with clinically assessed and angiographically assessed vascular damage.\n                    <jats:italic>In vitro<\/jats:italic>\n                    experiments suggest the potential to target arterial wall fibrosis in TAK with leflunomide, tofacitinib, baricitinib, or mTORC1 inhibitors. Since arterial wall inflammation is followed by fibrosis, a strategy of combining immunosuppressive agents with drugs that have an antifibrotic effect merits exploration in future clinical trials of TAK.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2023.1174249","type":"journal-article","created":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T08:33:56Z","timestamp":1684139636000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Arterial wall fibrosis in Takayasu arteritis and its potential for therapeutic modulation"],"prefix":"10.3389","volume":"14","author":[{"given":"Durga Prasanna","family":"Misra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kritika","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikas","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41572-021-00327-5","article-title":"Large-Vessel vasculitis","volume":"7","author":"Pugh","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.4081\/reumatismo.2018.1096","article-title":"Histopathology of vasculitis","volume":"70","author":"Bajocchi","year":"2018","journal-title":"Reumatismo"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2011.08.001","article-title":"Pathogenesis of takayasu's arteritis: a 2011 update","volume":"11","author":"Arnaud","year":"2011","journal-title":"Autoimmun Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.760686","article-title":"Aortitis","volume":"117","author":"Gornik","year":"2008","journal-title":"Circulation"},{"key":"B5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1177\/1358863X18802989","article-title":"Pathogenesis of Large vessel vasculitis: implications for disease classification and future therapies","volume":"24","author":"Harky","year":"2018","journal-title":"Vasc Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1080\/1744666X.2016.1224180","article-title":"Large Vessel vasculitis: the search for response biomarkers","volume":"12","author":"Tombetti","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185x.13285","article-title":"Recent advances in the management of takayasu arteritis","author":"Misra","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3390\/life12111904","article-title":"Comparison of presentation and prognosis of takayasu arteritis with or without stroke or transient ischemic attack-a retrospective cohort study","volume":"12","author":"Misra","year":"2022","journal-title":"Life (Basel)"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-021-04958-5","article-title":"Corticosteroid monotherapy for the management of takayasu arteritis-a systematic review and meta-analysis","volume":"41","author":"Misra","year":"2021","journal-title":"Rheumatol Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-05743-2","article-title":"Disease-modifying anti-rheumatic drugs for the management of takayasu arteritis\u2013a systematic review and meta-analysis","volume":"40","author":"Misra","year":"2021","journal-title":"Clin Rheumatol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s10067-021-05973-4","article-title":"A systematic review of clinical and preclinical evidences for janus kinase inhibitors in Large vessel vasculitis","volume":"41","author":"Rathore","year":"2022","journal-title":"Clin Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2023.103275","article-title":"The effectiveness of tocilizumab and its comparison with tumor necrosis factor alpha inhibitors for takayasu arteritis: a systematic review and meta-analysis","volume":"22","author":"Misra","year":"2023","journal-title":"Autoimmun Rev"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.12.009","article-title":"A scoping review of the use of non-biologic disease modifying anti-rheumatic drugs in the management of Large vessel vasculitis","volume":"16","author":"Misra","year":"2017","journal-title":"Autoimmun Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2016.02.012","article-title":"Biotherapies in Large vessel vasculitis","volume":"15","author":"Ferfar","year":"2016","journal-title":"Autoimmun Rev"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12102565","article-title":"Outcome measures and biomarkers for disease assessment in takayasu arteritis","volume":"12","author":"Misra","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B16","doi-asserted-by":"publisher","first-page":"15979","DOI":"10.1038\/s41598-018-34395-7","article-title":"Novel angiographic scores for evaluation of Large vessel vasculitis","volume":"8","author":"Tombetti","year":"2018","journal-title":"Sci Rep"},{"key":"B17","article-title":"Assessment of disease activity and progression in takayasu's arteritis","volume":"29","author":"Direskeneli","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1517\/21678707.2013.827570","article-title":"Management options for takayasu arteritis","volume":"1","author":"Tombetti","year":"2013","journal-title":"Expert Opin Orphan Drugs"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2020.173090","article-title":"Macrophage M1\/M2 polarization","volume":"877","author":"Yunna","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.646516","article-title":"Potential role of macrophage phenotypes and Ccl2 in the pathogenesis of takayasu arteritis","volume":"12","author":"Kong","year":"2021","journal-title":"Front Immunol"},{"key":"B21","first-page":"69","article-title":"The potential role of leflunomide in inhibiting vascular fibrosis by down-regulating type-ii macrophages in takayasu's arteritis","author":"Cui","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1742-481X.2009.00651.x","article-title":"The role of mast cells in wound healing","volume":"7","author":"Ng","year":"2010","journal-title":"Int Wound J"},{"key":"B23","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jaci.2021.05.003","article-title":"Mast cells drive pathologic vascular lesions in takayasu arteritis","volume":"149","author":"Le Joncour","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0269-2020","article-title":"The promise of mtor as a therapeutic target pathway in idiopathic pulmonary fibrosis","volume":"29","author":"Plat\u00e9","year":"2020","journal-title":"Eur Respir Rev"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1312890","article-title":"Inhibition of the mtorc pathway in the antiphospholipid syndrome","volume":"371","author":"Canaud","year":"2014","journal-title":"N Engl J Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-07858-8","article-title":"The Mtorc1\/4e-Bp1 axis represents a critical signaling node during fibrogenesis","volume":"10","author":"Woodcock","year":"2019","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1002\/art.41084","article-title":"Targeting mechanistic target of rapamycin complex 1 restricts proinflammatory T cell differentiation and ameliorates takayasu arteritis","volume":"72","author":"Zhang","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/art.42103","article-title":"Critical role of notch-1 in mechanistic target of rapamycin hyperactivity and vascular inflammation in patients with takayasu arteritis","volume":"74","author":"Jiang","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.jaut.2018.07.013","article-title":"Mtor pathway activation in Large vessel vasculitis","volume":"94","author":"Maciejewski-Duval","year":"2018","journal-title":"J Autoimmun"},{"key":"B30","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1615\/ForumImmunDisTher.2015014188","article-title":"Reinvigorating exhausted T cells by blockade of the pd-1 pathway","volume":"6","author":"Lee","year":"2015","journal-title":"For Immunopathol Dis Therap"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aar8356","article-title":"Pd-1 up-regulation on Cd4(+) T cells promotes pulmonary fibrosis through Stat3-mediated il-17a and tgf-\u03921 production","volume":"10","author":"Celada","year":"2018","journal-title":"Sci Transl Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/art.39037","article-title":"Th1 and Th17 cytokines drive inflammation in takayasu arteritis","volume":"67","author":"Saadoun","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/7841718","article-title":"Increased circulating Th17 cells, serum il-17a, and il-23 in takayasu arteritis","volume":"2016","author":"Misra","year":"2016","journal-title":"Autoimmune Dis"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S355881","article-title":"Novel Th17 lymphocyte populations, Th17.1 and Pd1+Th17, are increased in takayasu arteritis, andboth Th17 and Th17.1 Sub-populations associate with active disease","volume":"15","author":"Singh","year":"2022","journal-title":"J Inflamm Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.immuni.2018.06.012","article-title":"Pd-1 controls follicular T helper cell positioning and function","volume":"49","author":"Shi","year":"2018","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/art.41672","article-title":"Specific follicular helper T cell signature in takayasu arteritis","volume":"73","author":"Desbois","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.9.5948","article-title":"Il-23 promotes maintenance but not commitment to the Th17 lineage","volume":"181","author":"Stritesky","year":"2008","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2013.05.024","article-title":"Two susceptibility loci to takayasu arteritis reveal a synergistic role of the Il12b and hla-b regions in a Japanese population","volume":"93","author":"Terao","year":"2013","journal-title":"Am J Hum Genet"},{"key":"B39","doi-asserted-by":"publisher","first-page":"13667","DOI":"10.1038\/s41598-021-93213-9","article-title":"A susceptibility locus in the Il12b but not Lilra3 region is associated with vascular damage in takayasu arteritis","volume":"11","author":"Kadoba","year":"2021","journal-title":"Sci Rep"},{"key":"B40","doi-asserted-by":"publisher","first-page":"F1000 Faculty Rev-2078","DOI":"10.12688\/f1000research.9207.1","article-title":"Mtor inhibitors in cancer therapy","volume":"5","author":"Xie","year":"2016","journal-title":"F1000Res"},{"key":"B41","first-page":"62","article-title":"Pro-fibrotic effect of il-6 Via aortic adventitial fibroblasts indicates il-6 as a treatment target in takayasu arteritis","volume":"36","author":"Kong","year":"2018","journal-title":"Clin Exp Rheumatol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jaut.2019.01.010","article-title":"Autophagy promotes aortic adventitial fibrosis Via the il-6\/Jak1 signaling pathway in takayasu's arteritis","volume":"99","author":"Chen","year":"2019","journal-title":"J\u00a0Autoimmun"},{"key":"B43","article-title":"Cyr61\/Tgf-\u0392 axis promotes adventitial fibrosis of takayasu's arteritis in the il-17 mediated inflammatory microenvironment","volume":"38","author":"Ma","year":"2020","journal-title":"Clin Exp Rheumatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-215567","article-title":"Takayasu arteritis risk locus in Il6 represses the anti-inflammatory gene gpnmb through chromatin looping and recruiting Mef2-hdac complex","volume":"78","author":"Kong","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1002\/art.39035","article-title":"Identification of susceptibility loci in Il6, Rps9\/Lilrb3, and an intergenic locus on chromosome 21q22 in takayasu arteritis in a genome-wide association study","volume":"67","author":"Renauer","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.tice.2021.101683","article-title":"Gpnmb plays an active role in the M1\/M2 balance","volume":"74","author":"Zhang","year":"2022","journal-title":"Tissue Cell"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2022.12.004","article-title":"A novel molecular mechanism of vascular fibrosis in takayasu arteritis: macrophage-derived gpnmb promoting adventitial fibroblast extracellular matrix production in the aorta","volume":"255","author":"Dai","year":"2023","journal-title":"Transl Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0166433","article-title":"Alternatively activated (M2) macrophage phenotype is inducible by endothelin-1 in cultured human macrophages","volume":"11","author":"Soldano","year":"2016","journal-title":"PloS One"},{"key":"B49","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13075-022-02740-x","article-title":"A comprehensive profile of chemokines in the peripheral blood and vascular tissue of patients with takayasu arteritis","volume":"24","author":"Kong","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-10-80","article-title":"Macrophage derived chemokine (Ccl22), thymus and activation-regulated chemokine (Ccl17), and Ccr4 in idiopathic pulmonary fibrosis","volume":"10","author":"Yogo","year":"2009","journal-title":"Respir Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068893","article-title":"Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction","volume":"8","author":"Tamaki","year":"2013","journal-title":"PloS One"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd8120187","article-title":"Enhanced liver fibrosis score as a biomarker for vascular damage assessment in patients with takayasu arteritis-a pilot study","volume":"8","author":"Stojanovic","year":"2021","journal-title":"J Cardiovasc Dev Dis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.10.058","article-title":"Sensitive assessment of activity of takayasu's arteritis by Pentraxin3, a new biomarker","volume":"57","author":"Ishihara","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.rbre.2015.08.007","article-title":"(18)F-fluorodeoxyglucose positron emission tomography and serum cytokines and matrix metalloproteinases in the assessment of disease activity in takayasu's arteritis","volume":"56","author":"Arraes","year":"2016","journal-title":"Rev Bras Reumatol Engl Ed"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.109.872903","article-title":"Th17 and Th1 T-cell responses in giant cell arteritis","volume":"121","author":"Deng","year":"2010","journal-title":"Circulation"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2010.21","article-title":"Interleukin-17 and its expanding biological functions","volume":"7","author":"Xu","year":"2010","journal-title":"Cell Mol Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00949","article-title":"Th17-inducing cytokines il-6 and il-23 are crucial for granuloma formation during experimental paracoccidioidomycosis","volume":"8","author":"Trist\u00e3o","year":"2017","journal-title":"Front Immunol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.128","article-title":"The crucial roles of Th17-related Cytokines\/Signal pathways in m","volume":"15","author":"Shen","year":"2018","journal-title":"Tuberculosis Infection Cell Mol Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1084\/jem.20130301","article-title":"Pro-inflammatory human Th17 cells selectively express p-glycoprotein and are refractory to glucocorticoids","volume":"211","author":"Ramesh","year":"2014","journal-title":"J Exp Med"},{"key":"B60","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1515\/bmc-2018-0007","article-title":"Interferon-gamma (Ifn-\u0393): exploring its implications in infectious diseases","volume":"9","author":"Kak","year":"2018","journal-title":"Biomol Concepts"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06202-2","article-title":"Th17.1 lymphocytes: emerging players in the orchestra of immune-mediated inflammatory diseases","volume":"41","author":"Misra","year":"2022","journal-title":"Clin Rheumatol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2005.09.010","article-title":"High tnf-alpha and low il-2 producing T cells characterize active disease in takayasu's arteritis","volume":"118","author":"Tripathy","year":"2006","journal-title":"Clin Immunol"},{"key":"B63","article-title":"New therapeutic targets in giant-cell arteritis. considerations based on the current pathogenic model and the availability of new therapeutic agents","volume":"26","author":"Lozano","year":"2008","journal-title":"Clin Exp Rheumatol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/annrheumdis-2019-215672","article-title":"2018 Update of the eular recommendations for the management of Large vessel vasculitis","volume":"79","author":"Hellmich","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050500","article-title":"Tnf-\u0391 modulates p-glycoprotein expression and contributes to cellular proliferation Via extracellular vesicles","volume":"8","author":"Berguetti","year":"2019","journal-title":"Cells"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.184.5.01841427","article-title":"Delayed contrast-enhanced mri of the aortic wall in takayasu's arteritis: initial experience","volume":"184","author":"Desai","year":"2005","journal-title":"AJR Am J Roentgenol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050655","article-title":"Delayed contrast-enhanced mri of the coronary artery wall in takayasu arteritis","volume":"7","author":"Schneeweis","year":"2012","journal-title":"PloS One"},{"key":"B68","doi-asserted-by":"publisher","first-page":"12388","DOI":"10.1038\/s41598-019-48709-w","article-title":"Pet\/Mri in Large-vessel vasculitis: clinical value for diagnosis and assessment of disease activity","volume":"9","author":"Laurent","year":"2019","journal-title":"Sci Rep"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.261925","article-title":"Fibroblast activation protein-specific Pet\/Ct imaging in fibrotic interstitial lung diseases and lung cancer: a translational exploratory study","volume":"63","author":"R\u00f6hrich","year":"2022","journal-title":"J Nucl Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1097\/rlu.0000000000003692","article-title":"68ga-fapi Pet\/Ct versus 18f-fdg Pet\/Ct for the evaluation of disease activity in takayasu arteritis","volume":"46","author":"Wu","year":"2021","journal-title":"Clin Nucl Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/key017","article-title":"Mtor pathway is activated in endothelial cells from patients with takayasu arteritis and is modulated by serum immunoglobulin G","volume":"57","author":"Hadjadj","year":"2018","journal-title":"Rheumatol (Oxford)"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12123102","article-title":"Impact of geographic location on diagnosis and initial management of takayasu arteritis: a tale of two cohorts from Italy and India","volume":"12","author":"Misra","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.51.6344","article-title":"A case of takayasu arteritis with repeated coronary artery restenosis after drug-eluting stent implantation successfully treated with a combination of steroids","volume":"51","author":"Yokota","year":"2012","journal-title":"Intern Med"},{"key":"B74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1183\/09031936.03.00014703","article-title":"Cytokine profiles in idiopathic pulmonary fibrosis suggest an important role for tgf-beta and il-10","volume":"22","author":"Bergeron","year":"2003","journal-title":"Eur Respir J"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20092121","article-title":"Bleomycin and il-1beta-Mediated pulmonary fibrosis is il-17a dependent","volume":"207","author":"Wilson","year":"2010","journal-title":"J Exp Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1174249\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T08:34:08Z","timestamp":1684139648000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1174249\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,15]]},"references-count":75,"alternative-id":["10.3389\/fimmu.2023.1174249"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1174249","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,15]]},"article-number":"1174249"}}